AHL
WST icon

Abel Hall LLC’s West Pharmaceutical WST Stock Holding History

Abel Hall LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204K Buy
+567
New +$173K 0.04% 733

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Abel Hall LLC's WST Position: Q2 2026 in Review

Abel Hall LLC opened a new position in West Pharmaceutical (WST) in Q2 2026: 567 shares worth $204K. The stake represents 0.04% of the portfolio and ranks #733 among its holdings.

265 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Abel Hall LLC held 567 shares of West Pharmaceutical worth $204K as of Q2 2026.
  • West Pharmaceutical was a new Abel Hall LLC position in Q2 2026.
  • West Pharmaceutical made up 0.04% of Abel Hall LLC's portfolio in Q2 2026, its #733 holding.
  • 265 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.